FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383873713> ?p ?o ?g. }

• W4383873713 endingPage "106730" @default.
• W4383873713 startingPage "106730" @default.
• W4383873713 abstract "According to WHO, infectious diseases are still a significant threat to public health. The combine effects of antibiotic resistance, immunopressure, and mutations within the bacterial and viral genomes necessitates the search for new molecules exhibiting antimicrobial and antiviral activities. Such molecules often contain cyclic guanidine moiety. As part of this work, we investigated the selected antimicrobial and antiviral activity of compounds from the cyclic arylguanidine group. Molecules were designed using molecular modeling and obtained using microwave radiation (MW) and sonochemical ()))) methods, in accordance with the previously developed pathways. The obtained compounds were screened for the ability to inhibit the growth of Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans, and Cryptococcus neoformans. The capacity to block the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the host cell was probed using a bioluminescence immunoassay. The cytotoxicity and hemolytic properties of the most active molecules were also evaluated. The N-[2-(naphthalen-1-yl)ethyl]-5-phenyl-1,4,5,6-tetrahydro-1,3,5-triazin-2-amine 12j showed a high inhibition of Staphylococcus aureus and Cryptococcus neoformans (MIC ≤ 0.25 µg/mL), with no cytotoxic nor hemolytic effect (CC50, HC10 > 32 µm/mL). The CO-ADD platform identified many potentially useful molecules. A particularly rich population was examined in the database of the N.D. Zelinsky Institute of Organic Chemistry, in which 2517 active molecules (MIC ≤ 32 mg/mL) were found, of which about 10% are active at very low concentrations (MIC ≤ 1 mg/mL)." @default.
• W4383873713 created "2023-07-12" @default.
• W4383873713 creator A5008442367 @default.
• W4383873713 creator A5008724133 @default.
• W4383873713 creator A5019786701 @default.
• W4383873713 creator A5052318171 @default.
• W4383873713 creator A5069944142 @default.
• W4383873713 date "2023-10-01" @default.
• W4383873713 modified "2023-09-25" @default.
• W4383873713 title "New cyclic arylguanidine scaffolds as a platform for development of antimicrobial and antiviral agents" @default.
• W4383873713 cites W1984847563 @default.
• W4383873713 cites W1990664237 @default.
• W4383873713 cites W1999662666 @default.
• W4383873713 cites W2000815209 @default.
• W4383873713 cites W2010932849 @default.
• W4383873713 cites W2025897603 @default.
• W4383873713 cites W2031168104 @default.
• W4383873713 cites W2059724811 @default.
• W4383873713 cites W2065146935 @default.
• W4383873713 cites W2067740761 @default.
• W4383873713 cites W2071555876 @default.
• W4383873713 cites W2072692396 @default.
• W4383873713 cites W2079473982 @default.
• W4383873713 cites W2089241061 @default.
• W4383873713 cites W2090812986 @default.
• W4383873713 cites W2102377211 @default.
• W4383873713 cites W2108464720 @default.
• W4383873713 cites W2108583965 @default.
• W4383873713 cites W2143981217 @default.
• W4383873713 cites W2180108487 @default.
• W4383873713 cites W2327191365 @default.
• W4383873713 cites W2330035135 @default.
• W4383873713 cites W2952516108 @default.
• W4383873713 cites W3012980526 @default.
• W4383873713 cites W3014067025 @default.
• W4383873713 cites W3044368832 @default.
• W4383873713 cites W3089557466 @default.
• W4383873713 cites W3101847458 @default.
• W4383873713 cites W3201236410 @default.
• W4383873713 cites W3211299676 @default.
• W4383873713 cites W4220772466 @default.
• W4383873713 cites W4295779503 @default.
• W4383873713 doi "https://doi.org/10.1016/j.bioorg.2023.106730" @default.
• W4383873713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37473481" @default.
• W4383873713 hasPublicationYear "2023" @default.
• W4383873713 type Work @default.
• W4383873713 citedByCount "0" @default.
• W4383873713 crossrefType "journal-article" @default.
• W4383873713 hasAuthorship W4383873713A5008442367 @default.
• W4383873713 hasAuthorship W4383873713A5008724133 @default.
• W4383873713 hasAuthorship W4383873713A5019786701 @default.
• W4383873713 hasAuthorship W4383873713A5052318171 @default.
• W4383873713 hasAuthorship W4383873713A5069944142 @default.
• W4383873713 hasBestOaLocation W43838737131 @default.
• W4383873713 hasConcept C104317684 @default.
• W4383873713 hasConcept C185592680 @default.
• W4383873713 hasConcept C2776315533 @default.
• W4383873713 hasConcept C2777637488 @default.
• W4383873713 hasConcept C2777893358 @default.
• W4383873713 hasConcept C2779489039 @default.
• W4383873713 hasConcept C2780917455 @default.
• W4383873713 hasConcept C2908647359 @default.
• W4383873713 hasConcept C4937899 @default.
• W4383873713 hasConcept C523546767 @default.
• W4383873713 hasConcept C54355233 @default.
• W4383873713 hasConcept C547475151 @default.
• W4383873713 hasConcept C55493867 @default.
• W4383873713 hasConcept C71924100 @default.
• W4383873713 hasConcept C86803240 @default.
• W4383873713 hasConcept C89423630 @default.
• W4383873713 hasConcept C99454951 @default.
• W4383873713 hasConceptScore W4383873713C104317684 @default.
• W4383873713 hasConceptScore W4383873713C185592680 @default.
• W4383873713 hasConceptScore W4383873713C2776315533 @default.
• W4383873713 hasConceptScore W4383873713C2777637488 @default.
• W4383873713 hasConceptScore W4383873713C2777893358 @default.
• W4383873713 hasConceptScore W4383873713C2779489039 @default.
• W4383873713 hasConceptScore W4383873713C2780917455 @default.
• W4383873713 hasConceptScore W4383873713C2908647359 @default.
• W4383873713 hasConceptScore W4383873713C4937899 @default.
• W4383873713 hasConceptScore W4383873713C523546767 @default.
• W4383873713 hasConceptScore W4383873713C54355233 @default.
• W4383873713 hasConceptScore W4383873713C547475151 @default.
• W4383873713 hasConceptScore W4383873713C55493867 @default.
• W4383873713 hasConceptScore W4383873713C71924100 @default.
• W4383873713 hasConceptScore W4383873713C86803240 @default.
• W4383873713 hasConceptScore W4383873713C89423630 @default.
• W4383873713 hasConceptScore W4383873713C99454951 @default.
• W4383873713 hasFunder F4320311904 @default.
• W4383873713 hasFunder F4320320984 @default.
• W4383873713 hasFunder F4320323930 @default.
• W4383873713 hasFunder F4320326535 @default.
• W4383873713 hasFunder F4320337160 @default.
• W4383873713 hasLocation W43838737131 @default.
• W4383873713 hasLocation W43838737132 @default.
• W4383873713 hasOpenAccess W4383873713 @default.
• W4383873713 hasPrimaryLocation W43838737131 @default.
• W4383873713 hasRelatedWork W1967858509 @default.

• next